Detalhe da pesquisa
1.
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.
Haematologica
; 108(3): 747-760, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263840
2.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Lancet
; 398(10299): 491-502, 2021 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097852
3.
Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK.
BMC Cancer
; 22(1): 735, 2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790913
4.
Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure.
Arch Toxicol
; 91(1): 289-300, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27146145
5.
Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
PLoS One
; 17(10): e0268352, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194587
6.
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Adv Ther
; 39(8): 3678-3695, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727476
7.
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
J Hematol Oncol
; 15(1): 170, 2022 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494725
8.
Correction: Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.
Oncotarget
; 8(38): 64651, 2017 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28969101
9.
Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide.
Leuk Res
; 2015 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26427727
10.
Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia.
Cancer Cell
; 22(5): 656-67, 2012 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153538
11.
Quantification of circulating endothelial progenitor cells in human peripheral blood: establishing a reliable flow cytometry protocol.
J Immunol Methods
; 357(1-2): 38-42, 2010 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-20381496